Maui Derm NP+PA Summer 2022 Conference

Cynthia J. Trickett, PA-C, MPAS, discusses the personal and clinical effects of atopic dermatitis in adult and pediatric patients at the Maui Derm NP+PA 2022 Summer Conference in Colorado Springs, Colorado.

Kenneth Gordon, MD, professor and chair of dermatology at the Medical College of Wisconsin, discusses new topical therapy treatment options for psoriasis and what he's looking forward to.

Melodie Young, MSN, A/GNP-C, nurse practitioner at Mindful Dermatology and a partner and sub-investigator with Modern Research Associates in Dallas, Texas, explains what NPs and PAs can bring to the dermatology space.

Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego and professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine, discusses new treatments and therapies for pediatric atopic dermatitis.

Minimally invasive method outperformed tape stripping in a recent study.

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains dives into what 2022 is bringing to the AD space.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the treatments for psoriatic arthritis, the comorbidities that have to be considered, and more.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, gives keys pearls on fillers and neuromodulators and what innovation is heading for the industry.

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains what allied health care workers can learn from his presentation.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the future of psoriatic arthritis.